Instructions for Florin Forte probiotic (bifidobacterium, lactobacillus)
English Product Name
Florin Forte
Release Form Florin Forte
caps: 10, 15, 20 or 30 pcs.
Powder with a faint sour-milk odor of light gray or dark gray color with black intersperses.
Description Florin Forte
The capsules are solid gelatin, the body is white, the lid is yellow; the contents of the capsules are light gray or dark gray powder with black intersperses, with a weak sour milk odor.
1 pack.
Bifidobacterium bifidum (sorbed on activated carbon) at least 50 million. KOE
Lactobacillus plantarum at least 50 million. KOE
Auxiliary substances: components of the drying medium (sugar-gelatin): sucrose - 8.08-8.24 mg, gelatin - 1.07-1.09 mg, activated carbon - 2.73-2.79 mg, magnesium stearate - 1-10 mg, lactose monohydrate - up to 2 g.
Capsule shell composition: capsule body - titanium dioxide (white color) 1.0-2.0%, gelatin up to 100%; capsule cap - titanium dioxide 1.0-2.0%, iron oxide (yellow color) 0.05-1.8%, gelatin up to 100%.
ATX codes
A07FA Antidiarrheal drugs of biological origin, regulating the balance of intestinal microflora
Clinical and pharmacological groups / Group affiliation
A drug that regulates the balance of intestinal flora (a probiotic)
Active ingredient probiotic
- Bifidobacterium bifidum
- Lactobacillus plantarum
Pharmacotherapeutic group Florin Forte
Probiotic
Method of use, course and dosage
They are applied internally.
The dose and treatment regimen of the drug are determined individually, depending on age, the indications used by the dosage form.
Special instructions Florin Forte
It is not recommended to use it with antimicrobials at the same time, as well as dissolving the drug in hot water (above 40°) and storing it in dissolved form.
- Nosology probiotic (ICD codes)
- A04
- Other bacterial intestinal infections
- A05
- Other bacterial food poisonings not elsewhere classified
- A08.0
- Enteritis due to rotavirus
- A09.0
- Other and unspecified gastroenteritis and colitis of infectious origin
- J06.9
- Acute upper respiratory infection, unspecified
- K52.9
- Noninfectious gastroenteritis and colitis, unspecified
- K63.8
- Other specified diseases of intestine
- Z54
- Convalescent state
pharmachologic effect Florin Forte
Probiotic microorganisms, such as bifidobacteria and lactobacteria, have a pharmacological effect on the human body. These nonpathogenic and nontoxigenic organisms, which are introduced into the intestine by food, favorably affect the composition and activity of the digestive tract microflora. Particularly useful organisms include the genera bifidobacterium, lactobacillus, propionibacterium, and lactococcus.
probiotic Bifidobacteria help maintain and improve the physiologic balance of intestinal flora and may restore deficiency of bifidobacteria. They are also active against a wide range of pathogenic and opportunistic microorganisms, neutralize toxic products of metabolism, promote the assimilation of minerals, proteins and carbohydrates. They also have vitamin-like vitamin B activity, prevent protracted intestinal infections, and increase nonspecific resistance.
Lactobacteria are an important part of the normal flora of the digestive and genital tract. They have diverse biological properties and are actively involved in the exchange and regulation of processes. Lactobacilli are strongly active against a wide range of aerobic and facultative-anaerobic gram-negative and gram-positive bacteria, as well as some obligatory-anaerobic microorganisms. Particularly pronounced activity is seen in lactobacillus acidophilus, l. plantarum, l. casei, l. fermentii, l. buchneri.
Bifidobacteria and lactobacteria interact synergistically to maintain and regulate the physiologic balance of intestinal flora. They increase intestinal mucosal resistance to pathogens, inhibit the movement of pathogenic bacteria into the colon, and are antagonistic to many pathogenic and opportunistic organisms. They also normalize immune performance when it is suppressed.
Indications for use include the following probiotic:
- Disorders that impair the normal flora of the intestine and a deficiency of beneficial probiotic bacteria
- such as bifidobacteria,
- probiotic Lactobacteria or normal E. coli; acute E. coli infections due to rotaviruses or opportunistic microflora;
- Acute intestinal infections of unknown cause
- Acute respiratory diseases caused by viruses
- and microbes; chronic diseases of the gastrointestinal tract, including identified hemolytic E. coli and associations of opportunistic microorganisms in large quantities; restoration of normal intestinal microflora during the convalescence after the past diseases;
- Dysbacteriosis of various origins